Our study revealed that compared to normal Tregs, AML Tregs were more capable of inhibiting proliferation, promoting apoptosis and suppressing the production of IFN-γ in both normal and AML CD4+CD25− T cells. Here, CD4 is linked to acute myeloid leukemia.